Research News & Studies

Topics

<< < (2/289) > >>

[1] MSD/Merck’s once-weekly phase 2 study stopped - NNRTI MK-8507

[2] HIV Time to Viral Rebound After Interruption of Modern ART. (ACTG) A5345

[3] Virologic Failure Following Low-level Viremia - Results Multicenter Cohort

[4] Broadly Neutralizing Antibodies - Broad in Theory, Narrow in Reality

[5] BANNER trial - N6LS - Neutralizing Antibody Shows Promise

[6] ACTGA5386

[7] Monoclonal Antibodies-Danish Study

[8] lung cancer incidence among PLHIV has fallen

[9] EBT-101

Navigation

[0] Up one level

[#] Next page

[*] Previous page